OBJECTIVE: There are only few studies on agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia (cAITP). MATERIALS AND METHODS: We compared agonist (TRAP-6, ADP, Arachidonic acid, Epinephrine, and Ristocetin) -inducible P-selectin expression and PAC-1 binding in 40 patients with cAITP (f/m ratio 23/17) with those in 20 healthy controls. Results were correlated with platelet counts, detectable platelet antibodies, and reticulated platelets. RESULTS: The in vivo activation of platelets determined the in vitro inducible response to agonists. The stronger the in vivo activation the less the number of platelets responding to agonists, as illustrated by the inverse correlation of P-selectin expression ex vivo and the relative increase after the exogenous addition of agonists. The agonist-inducible platelet activation was not associated with the presence of detectable platelet antibodies to GPIb/IX or GPIIb/IIIa. Agonist-inducible platelet activation was also not correlated with counts of reticulated platelets. CONCLUSION: Agonist-inducible activation of platelets in cAITP is affected mainly by their in vivo activation.
OBJECTIVE: There are only few studies on agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia (cAITP). MATERIALS AND METHODS: We compared agonist (TRAP-6, ADP, Arachidonic acid, Epinephrine, and Ristocetin) -inducible P-selectin expression and PAC-1 binding in 40 patients with cAITP (f/m ratio 23/17) with those in 20 healthy controls. Results were correlated with platelet counts, detectable platelet antibodies, and reticulated platelets. RESULTS: The in vivo activation of platelets determined the in vitro inducible response to agonists. The stronger the in vivo activation the less the number of platelets responding to agonists, as illustrated by the inverse correlation of P-selectin expression ex vivo and the relative increase after the exogenous addition of agonists. The agonist-inducible platelet activation was not associated with the presence of detectable platelet antibodies to GPIb/IX or GPIIb/IIIa. Agonist-inducible platelet activation was also not correlated with counts of reticulated platelets. CONCLUSION: Agonist-inducible activation of platelets in cAITP is affected mainly by their in vivo activation.
Authors: B Psaila; J B Bussel; A L Frelinger; B Babula; M D Linden; Y Li; M R Barnard; C Tate; E J Feldman; A D Michelson Journal: J Thromb Haemost Date: 2011-11 Impact factor: 5.824
Authors: Bethan Psaila; James B Bussel; Matthew D Linden; Bracken Babula; Youfu Li; Marc R Barnard; Chinara Tate; Kanika Mathur; Andrew L Frelinger; Alan D Michelson Journal: Blood Date: 2012-01-31 Impact factor: 22.113
Authors: Andrew L Frelinger; Rachael F Grace; Anja J Gerrits; Michelle A Berny-Lang; Travis Brown; Sabrina L Carmichael; Ellis J Neufeld; Alan D Michelson Journal: Blood Date: 2015-07-02 Impact factor: 22.113
Authors: Alexey A Martyanov; Daria S Morozova; Maria A Sorokina; Aleksandra A Filkova; Daria V Fedorova; Selima S Uzueva; Elena V Suntsova; Galina A Novichkova; Pavel A Zharkov; Mikhail A Panteleev; And Anastasia N Sveshnikova Journal: Int J Mol Sci Date: 2020-04-25 Impact factor: 5.923